Analystreport

Revance Therapeutics, Inc. (NASDAQ: RVNC) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating.

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com